We are live on ! Find out more
FNCH

Finch Therapeutics Group, Inc. Common Stock
FNCH

Delisted

FNCH was delisted on the 24th of May, 2024.

Back to rankings

51 hedge funds and large institutions have $115M invested in Finch Therapeutics Group, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

143% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 7

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

16% more funds holding

Funds holding: 44 → 51 (+7)

8% more capital invested

Capital invested by funds: $107M → $115M (+$8.18M)

Holders
51
Holders Change
+7
Holders Change %
+15.91%
% of All Funds
0.78%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
10
Increased
17
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MP
MSD Partners
New York
+$9.94M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$7.93M
3
LSAG
Lake Street Advisors Group
New Hampshire
+$1.32M
4
Citadel Advisors
Citadel Advisors
Florida
+$988K
5
E
Ergoteles
New York
+$816K

Top Sellers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
-$970K
2
AI
Aperture Investors
New York
-$470K
3
FMBTD
First Midwest Bank Trust Division
Illinois
-$342K
4
Vontobel Holding
Vontobel Holding
Switzerland
-$325K
5
Wells Fargo
Wells Fargo
California
-$230K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$273K +$110K +288 +46%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$255K +$4.99K +13 +2%
Qube Research & Technologies (QRT)
28
Qube Research & Technologies (QRT)
United Kingdom
$244K +$313K +817 New
HighTower Advisors
29
HighTower Advisors
Illinois
$180K – – –
Bank of America
30
Bank of America
North Carolina
$143K +$150K +390 +438%
Millennium Management
31
Millennium Management
New York
$126K +$161K +421 New
AA
32
Ancora Advisors
Ohio
$119K +$63.7K +166 +72%
N
33
Nuveen
North Carolina
$111K – – –
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
$66K – – –
UBS Group
35
UBS Group
Switzerland
$52K +$46K +120 +226%
JP Morgan Chase
36
JP Morgan Chase
New York
$48K +$2.68K +7 +5%
Deutsche Bank
37
Deutsche Bank
Germany
$46K +$3.07K +8 +6%
Wells Fargo
38
Wells Fargo
California
$42K -$230K -600 -81%
AIG
39
American International Group
New York
$40K -$1.53K -4 -3%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$40K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$32K -$1.92K -5 -5%
SPIA
42
Steward Partners Investment Advisory
New York
$22K – – –
Citigroup
43
Citigroup
New York
$19K +$13K +34 +117%
SO
44
STRS Ohio
Ohio
$17K – – –
Royal Bank of Canada
45
Royal Bank of Canada
Ontario, Canada
$16K +$11.1K +29 +112%
TRCT
46
Tower Research Capital (TRC)
New York
$15K +$8.05K +21 +75%
AIP
47
Ameritas Investment Partners
Nebraska
$6K – – –
Legal & General Group
48
Legal & General Group
United Kingdom
$6K – – –
Northwestern Mutual Wealth Management
49
Northwestern Mutual Wealth Management
Wisconsin
$6K – – –
Lazard Asset Management
50
Lazard Asset Management
New York
$1K +$1.92K +5 New
1
2
3

FNCH Hedge Fund Activity: Q4 2021 in Review

51 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Finch Therapeutics Group, Inc. Common Stock (FNCH) for Q4 2021, worth a combined $115M — up 7.7% from $107M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new FNCH positions and 3 closed out — a net gain of 7 holders — while 17 added to existing stakes and 7 trimmed.

The largest buyer was MSD Partners, adding an estimated $9.94M. The largest seller was Baupost Group, cutting an estimated $970K.

  • 51 institutional investors held Finch Therapeutics Group, Inc. Common Stock (FNCH) as of Q4 2021, up from 44 in Q3 2021.
  • Funds reported $115M of Finch Therapeutics Group, Inc. Common Stock stock for Q4 2021, up 7.7% quarter-over-quarter.
  • 10 funds opened new Finch Therapeutics Group, Inc. Common Stock positions in Q4 2021 and 3 closed out, a net change of +7 holders.
  • The largest Finch Therapeutics Group, Inc. Common Stock buyer in Q4 2021 was MSD Partners, an estimated $9.94M added.
  • The largest Finch Therapeutics Group, Inc. Common Stock seller in Q4 2021 was Baupost Group, an estimated $970K sold.

Based on aggregated 13F filings for Q4 2021.